Sign In
Get Clay Free →

Suggestions

    Daniela van Eickels

    Executive Director Global Medical Affairs bei Kite Pharma

    Daniela van Eickels, MD, MPH, is a prominent figure in the field of cell therapy and medical affairs. She currently holds the position of Vice President and Head of Medical Affairs for Bristol Myers Squibb's Cell Therapy Organization.45 In this role, she is actively involved in advancing cell therapy research and development, particularly for autoimmune diseases.

    Career Highlights

    • Leadership in ACTioN: Dr. van Eickels serves as a co-chair of ACTioN (Autoimmunity Cell Therapy Network), a global collaborative effort by Bristol Myers Squibb to accelerate the development of cell therapies for autoimmune diseases.12

    • Expertise in Cell Therapy: She is deeply involved in the application of CAR T-cell therapy, which has shown success in treating certain blood cancers, to autoimmune diseases.1

    • Medical Affairs Leadership: At Bristol Myers Squibb, she leads medical affairs efforts in the cell therapy organization, focusing on expanding the potential of these treatments.45

    Research and Development Focus

    Dr. van Eickels is particularly interested in:

    • Transferring the concept of selectively targeting cells from cancer treatment to autoimmune diseases.1
    • Addressing unmet needs in autoimmune disease treatment through cell therapy.5
    • Facilitating interdisciplinary collaboration among scientists, clinicians, and patient advocates to advance cell therapy research.1

    Professional Background

    While her current role is with Bristol Myers Squibb, it's worth noting that her LinkedIn profile suggests previous experience at Kite Pharma, which is now part of Gilead Sciences.3 However, the most recent and prominent information indicates her leadership position at Bristol Myers Squibb's Cell Therapy Organization.

    Dr. van Eickels is actively involved in presenting and discussing the potential of cell therapies for autoimmune diseases at professional conferences and in medical publications.45

    Highlights

    Oct 8 · cgtlive.com
    Daniela van Eickels, MD, PhD, MPH, on Bristol Myers Squibb's ...
    Oct 6 · cgtlive.com
    Daniela van Eickels, MD, PhD, MPH, on Addressing Unmet Needs ...
    Daniela van Eickels, MD, PhD, MPH, on Addressing Unmet Needs ...
    May 9 · kitepharma.com
    Kite and Arcellx Continue Momentum with Advances in Anito-Cel ...
    Dec 9 · cgtlive.com
    Daniela van Eickels, MD, PhD, MPH - CGTLive®
    Nov 1 · bms.com
    Taking ACTioN to advance CAR T cell therapy for autoimmune ...

    Related Questions

    What are Daniela van Eickels' main responsibilities at Kite Pharma?
    How has Daniela van Eickels contributed to the development of CAR T-cell therapies?
    What is the significance of the iMMagine-3 trial for Kite Pharma?
    How does Kite Pharma's collaboration with Arcellx impact their medical affairs?
    What are the key advancements in cell therapy at Kite Pharma under Daniela van Eickels' leadership?
    Daniela van Eickels
    Daniela van Eickels, photo 1
    Daniela van Eickels, photo 2
    Get intro to Daniela
    Add to my network

    Location

    Greater Los Angeles Area